This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

BILN 2061

Boehringer Ingelheim GmbH

Drug Names(s): BILN 2061 h

Description: BILN 2061 is a novel oral HCV serine protease inhibitor.

BILN 2061 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug